Nexalin Technology, Inc. (NXL)
1.86
-0.17
(-8.37%)
USD |
NASDAQ |
Oct 23, 16:00
1.86
0.00 (0.00%)
After-Hours: 20:00
Nexalin Technology EPS Diluted (Quarterly) : -3.177 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.177 |
| March 31, 2026 | -3.174 |
| December 31, 2025 | -3.829 |
| September 30, 2025 | -3.838 |
| June 30, 2025 | -3.017 |
| March 31, 2025 | -4.483 |
| December 31, 2024 | -6.389 |
| September 30, 2024 | -6.771 |
| June 30, 2024 | -5.140 |
| March 31, 2024 | -4.200 |
| December 31, 2023 | -3.149 |
| September 30, 2023 | -9.294 |
| Date | Value |
|---|---|
| June 30, 2023 | -3.386 |
| March 31, 2023 | -3.081 |
| December 31, 2022 | -3.004 |
| September 30, 2022 | -0.558 |
| June 30, 2022 | -1.811 |
| March 31, 2022 | -1.621 |
| December 31, 2021 | -2.456 |
| September 30, 2021 | -7.416 |
| June 30, 2021 | -8.653 |
| March 31, 2021 | -6.522 |
| December 31, 2020 | -1.884 |
| September 30, 2020 | -3.121 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.0154 |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -0.3862 |
| ResMed, Inc. | 2.645 |
| Rockwell Medical, Inc. | -0.3352 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.239M |
| Revenue (Quarterly) | 0.0122M |
| Total Expenses (Quarterly) | 2.251M |
| Enterprise Value | 0.3593M |
| Gross Profit Margin (Quarterly) | -4.23K% |
| Profit Margin (Quarterly) | -18.35K% |
| Earnings Yield | -753.6% |
| Normalized Earnings Yield | -753.61 |